[Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].
Viloxazine administered as a unique antidepressant may in some cases cause an aggravation of anxiety and agitation or manic states. In order to control this effect, we thought of administering neuroleptics and anxiolytics: 1) Before Viloxazine for a few days. 2) Then during antidepressant treatment. The results were as follow: 1) Quick and efficient upon melancholic states in manic -- depressive psychoses. 2) Irregular and questionable upon other depressions.
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D002746:Chlorpromazine / Q000008:administration & dosage; D003863:Depression / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000008:administration & dosage; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage*; D013469:Sulpiride / Q000008:administration & dosage; D014149:Tranquilizing Agents / Q000008:administration & dosage*; D014745:Viloxazine / Q000008:administration & dosage*
D009025:Morpholines; D014149:Tranquilizing Agents; D014745:Viloxazine; D013469:Sulpiride; D008728:Methotrimeprazine; D006220:Haloperidol; D002746:Chlorpromazine
Chimiothérapie de la mélancolie par l'association séquentielle neuroleptique-viloxazine